BRPI0914473A2 - "célula-tronco de próstata e de câncer de próstata, métodos de isolamento de uma célula-tronco de próstata e de seleção de um paciente com câncer de próstata e métodos para inibir a proliferação de uma célula-tronco de próstata, para a prevenção de recidiva de câncer de próstata, para tratamento de câncer de próstata, para fornecimento de terapia adjuvante, para promover o crescimento ou reparação do tecido da próstata, para promover o crescimento da próstata, para fornecimento de próstata funcional e para selecionar um composto" - Google Patents
"célula-tronco de próstata e de câncer de próstata, métodos de isolamento de uma célula-tronco de próstata e de seleção de um paciente com câncer de próstata e métodos para inibir a proliferação de uma célula-tronco de próstata, para a prevenção de recidiva de câncer de próstata, para tratamento de câncer de próstata, para fornecimento de terapia adjuvante, para promover o crescimento ou reparação do tecido da próstata, para promover o crescimento da próstata, para fornecimento de próstata funcional e para selecionar um composto"Info
- Publication number
- BRPI0914473A2 BRPI0914473A2 BRPI0914473A BRPI0914473A BRPI0914473A2 BR PI0914473 A2 BRPI0914473 A2 BR PI0914473A2 BR PI0914473 A BRPI0914473 A BR PI0914473A BR PI0914473 A BRPI0914473 A BR PI0914473A BR PI0914473 A2 BRPI0914473 A2 BR PI0914473A2
- Authority
- BR
- Brazil
- Prior art keywords
- prostate
- prostate cancer
- methods
- stem cell
- promoting
- Prior art date
Links
- 210000002307 prostate Anatomy 0.000 title 6
- 206010060862 Prostate cancer Diseases 0.000 title 5
- 208000000236 Prostatic Neoplasms Diseases 0.000 title 5
- 210000000130 stem cell Anatomy 0.000 title 3
- 238000000034 method Methods 0.000 title 2
- 230000001737 promoting effect Effects 0.000 title 2
- 238000009098 adjuvant therapy Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 230000035755 proliferation Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
- C12N5/0683—Cells of the male genital tract, e.g. prostate, epididymis; Non-germinal cells from testis, e.g. Leydig cells, Sertoli cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0693—Tumour cells; Cancer cells
- C12N5/0695—Stem cells; Progenitor cells; Precursor cells
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Reproductive Health (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Developmental Biology & Embryology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19693008P | 2008-10-22 | 2008-10-22 | |
| PCT/US2009/061473 WO2010048278A1 (en) | 2008-10-22 | 2009-10-21 | Prostate stem cells and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0914473A2 true BRPI0914473A2 (pt) | 2019-09-24 |
Family
ID=41625152
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0914473A BRPI0914473A2 (pt) | 2008-10-22 | 2009-10-21 | "célula-tronco de próstata e de câncer de próstata, métodos de isolamento de uma célula-tronco de próstata e de seleção de um paciente com câncer de próstata e métodos para inibir a proliferação de uma célula-tronco de próstata, para a prevenção de recidiva de câncer de próstata, para tratamento de câncer de próstata, para fornecimento de terapia adjuvante, para promover o crescimento ou reparação do tecido da próstata, para promover o crescimento da próstata, para fornecimento de próstata funcional e para selecionar um composto" |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20110262465A1 (pt) |
| EP (1) | EP2342225A1 (pt) |
| JP (1) | JP2012506255A (pt) |
| KR (1) | KR20110073534A (pt) |
| CN (1) | CN102203131A (pt) |
| AU (1) | AU2009307651A1 (pt) |
| BR (1) | BRPI0914473A2 (pt) |
| CA (1) | CA2740241A1 (pt) |
| IL (1) | IL211994A0 (pt) |
| MX (1) | MX2011004165A (pt) |
| WO (1) | WO2010048278A1 (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013532482A (ja) | 2010-07-27 | 2013-08-19 | ジェノミック ヘルス， インコーポレイテッド | 遺伝子発現を用いた前立腺癌の予後を定量化する方法 |
| US9540443B2 (en) | 2011-01-26 | 2017-01-10 | Kolltan Pharmaceuticals, Inc. | Anti-kit antibodies |
| TWI596113B (zh) | 2012-07-25 | 2017-08-21 | 塞爾德克斯醫療公司 | 抗ｋｉｔ抗體及其用途 |
| AU2014261788B2 (en) * | 2013-04-29 | 2019-07-11 | Nantes Université | Targeting O-acetylated GD2 ganglioside as a new therapeutic and diagnostic strategy for Cancer Stem Cells Cancer |
| JP6768639B2 (ja) | 2014-05-23 | 2020-10-21 | セルデックス セラピューティクス，インコーポレーテッド | 好酸球又はマスト細胞関連障害の治療 |
| WO2019075403A1 (en) * | 2017-10-12 | 2019-04-18 | General Electric Company | Prognostic characterization of biological sample |
| JP7642531B2 (ja) | 2018-05-11 | 2025-03-10 | ビーム セラピューティクス インク． | プログラム可能塩基エディターシステムを用いて病原性アミノ酸を置換する方法 |
-
2009
- 2009-10-21 WO PCT/US2009/061473 patent/WO2010048278A1/en not_active Ceased
- 2009-10-21 CN CN2009801421931A patent/CN102203131A/zh active Pending
- 2009-10-21 EP EP09740612A patent/EP2342225A1/en not_active Withdrawn
- 2009-10-21 BR BRPI0914473A patent/BRPI0914473A2/pt not_active IP Right Cessation
- 2009-10-21 KR KR1020117009087A patent/KR20110073534A/ko not_active Withdrawn
- 2009-10-21 US US13/124,428 patent/US20110262465A1/en not_active Abandoned
- 2009-10-21 JP JP2011533294A patent/JP2012506255A/ja active Pending
- 2009-10-21 AU AU2009307651A patent/AU2009307651A1/en not_active Abandoned
- 2009-10-21 MX MX2011004165A patent/MX2011004165A/es not_active Application Discontinuation
- 2009-10-21 CA CA2740241A patent/CA2740241A1/en not_active Abandoned
-
2011
- 2011-03-29 IL IL211994A patent/IL211994A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20110262465A1 (en) | 2011-10-27 |
| JP2012506255A (ja) | 2012-03-15 |
| EP2342225A1 (en) | 2011-07-13 |
| IL211994A0 (en) | 2011-06-30 |
| AU2009307651A1 (en) | 2010-04-29 |
| CA2740241A1 (en) | 2010-04-29 |
| MX2011004165A (es) | 2011-08-08 |
| CN102203131A (zh) | 2011-09-28 |
| WO2010048278A1 (en) | 2010-04-29 |
| KR20110073534A (ko) | 2011-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0914473A2 (pt) | "célula-tronco de próstata e de câncer de próstata, métodos de isolamento de uma célula-tronco de próstata e de seleção de um paciente com câncer de próstata e métodos para inibir a proliferação de uma célula-tronco de próstata, para a prevenção de recidiva de câncer de próstata, para tratamento de câncer de próstata, para fornecimento de terapia adjuvante, para promover o crescimento ou reparação do tecido da próstata, para promover o crescimento da próstata, para fornecimento de próstata funcional e para selecionar um composto" | |
| WO2009114703A3 (en) | Combination therapy for the treatment of cancer | |
| AU2018256546A1 (en) | Combination therapy with peptide epoxyketones | |
| BR112012013398A2 (pt) | imunoterapia adjuvante para o tratamento preventivo, curativo ou paliativo de doenças sistêmicas crônicas tais como o câncer, de manifestações clinicas associados a estas doenças, tal como a caquexia e correção dos efeitos adversos de medicamentos e tratamentos tais como a imunodepressão, neutripenia e infopenia, compreendendo a associação ou combinação de um modioficador de resposta biologica especialmente elecionado e outros compostos com ação antineoplástica e/ ou outros tratamentos | |
| IL209231A0 (en) | Scoring catheter for treating diseased heart valves | |
| EP2759302A3 (en) | 4F-benzoyl-TN14003 combined with rituximab for use in the treatment of a tumour | |
| DE602005025735D1 (de) | Mesoporöse beschichtungen für medizinische implantate mit katalysator | |
| MX361467B (es) | Compuestos de isoindolina para uso en el tratamiento de cancer. | |
| WO2012002760A3 (ko) | 세균유래 마이크로베시클을 이용한 암치료 및 암진단 방법 | |
| TW200942552A (en) | Combination therapy with c-Met and HER antagonists | |
| WO2010019271A8 (en) | Fluorescent regulators of rassf1a expression and human cancer cell proliferation | |
| BR112012031727A2 (pt) | conjugado de droga-anticorpo, composição farmacêutica, uso do conjugado de droga-anticorpo, método para induzir a eliminação celular ou inibir o crescimento e/ou a proliferação de uma célula tumoral, e, método de tratamento de doença. | |
| GB0700560D0 (en) | Device and method for the treatment of diseased tissue such as tumours | |
| WO2009099677A3 (en) | Therapeutic peptidomimetic macrocycles | |
| WO2008021183A3 (en) | For the identification, assessment, and treatment of patients with cancer therapy | |
| WO2008031551A3 (en) | Non-neuroendocrine cancer therapy | |
| EP3195868A3 (en) | Therapeutic use of a tlr agonist and combination therapy | |
| EA201290356A1 (ru) | Композиции для лечения тошноты и рвоты центрального происхождения | |
| WO2008086182A3 (en) | Use of gene signatures to design novel cancer treatment regimens | |
| HK1197276A1 (en) | Methods and compositions for the treatment and diagnosis of bladder cancer | |
| WO2009149106A3 (en) | Microparticles for the treatment of disease | |
| SI2328417T1 (sl) | Spojine, sestavki in postopki za zdravljenje beta amiloidnih bolezni in sinukleinopatije | |
| EP1962839A4 (en) | ADMINISTRATION OF A MNTOR INHIBITOR FOR THE TREATMENT OF PATIENTS WITH CANCER | |
| BRPI0810384B8 (pt) | terapia enzimática anticâncer | |
| WO2008060945A3 (en) | Diagnosis and treatment of breast cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |